Orris

Tramadol pediatrics dose

Reading File
Finding Sources
Searching PubMed

"tramadol" AND "children"

Searching the Web

tramadol pediatric dosing FDA warning contraindication age

Finding Sources
Finding Sources
Finding Sources
Harriet Lane Handbook has a specific "Tramadol" entry - let me pull it.
Reading File
Reading File
Reading File

Tramadol in Pediatrics

Bottom line: Tramadol is contraindicated in children under 12 years of age for any indication, and contraindicated in patients under 18 years following tonsillectomy and/or adenoidectomy. There is no recommended pediatric dose because the FDA and most authoritative pediatric references advise against its use.

FDA Safety Restrictions (2017 boxed warning)

  • Under 12 years: contraindicated for pain of any kind.
  • Under 18 years: contraindicated for post-tonsillectomy/adenoidectomy pain management.
  • 12-18 years: not recommended in adolescents who are obese, or who have obstructive sleep apnea, severe lung disease, or other conditions that increase risk of respiratory depression - use only if benefits clearly outweigh risks, with close monitoring.
  • The same restrictions that apply to codeine (a related ultra-rapid CYP2D6 metabolizer risk) apply to tramadol.
Source: - The Harriet Lane Handbook, 23rd ed., p. 6160 ("In 2017 the FDA issued its strongest warning against use in children; therefore, administration is considered off label"); - Rosen's Emergency Medicine, 10th ed. (tramadol carries the same warning as codeine against use in 12-18 year-olds with obesity, OSA, or severe lung disease); - QDOLO (tramadol oral solution) prescribing label, FDA.

Why it's restricted

Tramadol is a prodrug metabolized by CYP2D6 to its active metabolite (O-desmethyltramadol, M1), which is the main driver of its opioid (mu-receptor) effect. Children who are CYP2D6 ultra-rapid metabolizers convert tramadol to M1 unusually fast, leading to dangerously high active-metabolite levels and case reports of fatal or near-fatal respiratory depression, especially after adenotonsillectomy for obstructive sleep apnea - this variability is unpredictable without genetic testing (- Miller's Anesthesia, 10th ed., p. 2126; - Tintinalli's Emergency Medicine).

If it is ever used off-label (specialist/palliative care settings only)

Some pediatric palliative care or anesthesia literature outside the US labeling (and in some countries where regulatory restrictions differ) has used tramadol in children over roughly 1 year old at approximate doses of 1-2 mg/kg/dose PO/IV every 4-6 hours (max ~8 mg/kg/day or 400 mg/day, whichever is lower) — but this is not an endorsed dose from the textbooks in this library, and should only be considered by a specialist after weighing the respiratory depression risk, never as routine first-line pediatric analgesia. Acetaminophen, ibuprofen, and when opioids are truly needed, morphine or other agents with more predictable metabolism are the preferred alternatives in children (- Harriet Lane Handbook, p. 6169-6190).

Recent evidence check

A 2023 meta-analysis (PMID: 36433693) looked specifically at topical tramadol applied to the peritonsillar space during pediatric adenotonsillectomy (a local, non-systemic route) for postoperative analgesia - this is a different context from systemic dosing and doesn't change the systemic contraindication above. No recent systematic reviews contradict the FDA contraindication for systemic pediatric use.
Practical takeaway: Don't dose tramadol in children under 12, and avoid it in adolescents 12-18 with respiratory risk factors or after tonsillectomy/adenoidectomy. Use acetaminophen, NSAIDs, or a monitored opioid alternative instead, and involve pediatric anesthesia/pain specialists if opioid therapy is genuinely needed.
This is a shared conversation. Sign in to Orris to start your own chat.